Skip to search formSkip to main contentSkip to account menu

TR 700

Known as: TR-700 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
OBJECTIVES To compare the activity of tedizolid (formally known as torezolid and TR-700) with that of 15 agents against a… 
Highly Cited
2012
Highly Cited
2012
ABSTRACT Tedizolid (TR-700, formerly torezolid) is the active moiety of the prodrug tedizolid phosphate (TR-701), a next… 
Highly Cited
2011
Highly Cited
2011
ABSTRACT Torezolid phosphate (TR-701) is the phosphate monoester prodrug of the oxazolidinone TR-700 which demonstrates potent in… 
Highly Cited
2010
Highly Cited
2010
ABSTRACT This study assessed the spectrum of activity of torezolid (TR-700), the active moiety of torezolid phosphate (TR-701… 
Highly Cited
2009
Highly Cited
2009
ABSTRACT TR-700 (torezolid), the active moiety of the novel oxazolidinone phosphate prodrug TR-701, is highly potent against gram… 
Highly Cited
2009
Highly Cited
2009
ABSTRACT TR-701 is the prodrug of the microbiologically active molecule TR-700, a novel orally and intravenously administered… 
Highly Cited
2009
Highly Cited
2009
BACKGROUND TR-700 is the active moiety of TR-701 (DA-7157), a new oral/intravenous oxazolidinone prodrug. We examined its… 
Highly Cited
2009
Highly Cited
2009
BACKGROUND AND AIMS Optimal treatment of infections caused by Staphylococcus aureus, Listeria monocytogenes and Legionella… 
2009
2009
BACKGROUND TR-700, the active component of the oxazolidinone prodrug TR-701, has demonstrated potent activity against numerous… 
Highly Cited
2008
Highly Cited
2008
ABSTRACT TR-701 is the orally active prodrug of TR-700, a novel oxazolidinone that demonstrates four- to eightfold-greater…